DOCSLIB.ORG

Forum for Innovative Regenerative Medicine Members As of Aug 1, 2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Forum for Innovative Regenerative Medicine Members As of Aug 1, 2021 Forum for Innovative Regenerative Medicine Members As of Aug 1, 2021 Representative Director, Ken-ichiro Hata Japan Tissue Engineering Co., Ltd. Chairperson Representative Director, Yoshitsugu Shitaka Astellas Pharma Inc. Vice Chairperson Vice-chairpersons Shigeharu Nishiuchi Hitachi, Ltd. Tohru Hirose Novartis Pharma K.K. Directors Mikitomo Yasutake Asahi Kasei Corporation Setsuko Hashimoto CellSeed Inc. Toshiki Sugimoto Dai Nippon Printing Co., Ltd. Masayuki Yabuta Daiichi Sankyo Co., Ltd. Yutaka Yamaguchi FUJIFILM Corporation Masakazu Kobayashi iPS PORTAL, Inc. Yuji Sato JCR Pharmaceuticals Co., Ltd. Yoshifumi Torii Kyowa Kirin Co., Ltd. Takashige Kondo MEDINET Co., Ltd. Osamu Takahashi PHC Corporation Kazuya Omi SRL, Inc. Toru Kimura Sumitomo Dainippon Pharma Co., Ltd. Masanobu Kimura TAKARA BIO INC. Keiji Iwashita Takeda Pharmaceutical Company Limited Kazuhisa Senshu TERUMO CORPORATION Supervisory Tadashi Sameshima Cellth DeC Board Members Hironao Yazaki Ernst & Young ShinNihon LLC Regular Members Regular Members ADEKA CORPORATION Hitachi, Ltd. Advantec kensyusenta HITACHIZOSEN CORPORATION AGC Inc. Hyperion Drug Discovery Co., Ltd Airex Co., Ltd. iHeart Japan Corporation AIRTECH JAPAN, LTD. IKARI SHODOKU CO., LTD. AJINOMOTO CO., INC. Ikeda Scientific, Co., Ltd. Alfresa Holdings Corporation iPS Academia Japan, Inc. Anderson Mori & Tomotsune iPS PORTAL, Inc. AnGes, Inc. Ipsos Healthcare Japan Limited Asahi Kasei Corporation IQVIA Services Japan K.K. Astellas Pharma Inc. Iwatani Corporation bioMerieux Japan Ltd. Janssen Pharmaceutical K.K. BIOMIMETICS SYMPATHIES Inc. Japan Tissue Engineering Co., Ltd. BrightPath Biotherapeutics Co., Ltd. JCR Pharmaceuticals Co., Ltd. Bristol Myers Squibb K.K. JMS CO., LTD. Celaid Therapeutics Inc. JSR Corporation Cell Exosome Therapeutics JTEC CORPORATION Cell Science & Technology Institute Inc. JUNTEN BIO Co., Ltd. CellBank Corp. Kaken Pharmaceutical Co., Ltd. CellGenTech, Inc. KANEKA CORPORATION CellSeed Inc. KANTO CHEMICAL CO., INC. CellSource Co., Ltd. Kirin Holdings Company, Limited CHIYODA CORPORATION Kohjin Bio Co., Ltd. chromocenter Inc. KOKEN CO., LTD. Chugai Pharmaceutical Co., Ltd. KYOCERA Corporation CMIC Co., Ltd. Kyokuto Pharmaceutical Industrial Co., Ltd. CPC Corporation KYORIN Pharmaceutical Co., Ltd. Cuorips Inc. Kyowa Kirin Co., Ltd. Cyfuse Biomedical K.K. Life Science Institute, Inc. Dai Nippon Printing Co., Ltd. Life Technologies Japan K.K. DAI-DAN CO., LTD. Lonza Japan Ltd. Daiichi Sankyo Co., Ltd. Lymphocyte-bank Co., Ltd. Denka Co., Ltd. Macrobiosis Inc. Earth Environmental Service Co., Ltd. MARUBISHI BIOENGINEERING Co., Ltd. EPS Corporation Maruho Co., Ltd. ESPEC CORP. MATRIXOME, Inc. Eurofins Analytical Science Laboratories, Inc. MEDINET Co., Ltd. FUJIFILM Corporation MEDIPAL HOLDINGS CORPORATION FUJIFILM Wako Pure Chemical Corporation Megakaryon Corporation FUJISOFT INCORPORATED Merck Ltd. FUKOKU CO., LTD. Metcela Inc. Funakoshi Co., Ltd. METRAS, Inc. Gene Techno Science Co., Ltd. MICRON Inc. Grandsoul Research Institute for Immunology, Inc. micronix Co., Ltd. HEALIOS K.K. Minaris Regenerative Medicine Co., Ltd. Heartseed Inc. 1 Forum for Innovative Regenerative Medicine Members As of Aug 1, 2021 Regular Members Regular Members Mitsubishi Chemical Corporation SANKI Engineering Co., Ltd. MITSUBISHI GAS CHEMICAL COMPANY, INC. SANPLATEC CORP. MITSUBISHI LOGISTICS CORPORATION Saraya Co., Ltd. Mitsui Fudosan Co., Ltd. SAROUTE Co., Ltd. Mitsui-soko Holdings Co., Ltd. Sartorius Stedim Japan K.K. MIURA CO., LTD SD Biosystem Co., Ltd. MOCHIDA PHARMACEUTICAL CO., LTD. Seed Planning, Inc. Myoridge Co. Ltd. SEIKEN CO., LTD. NanoCarrier Co., Ltd. SHIBAMATA TRANSPORT Co., Ltd. Nard institute, LTD. SHIBUYA KOGYO CO., LTD. Nexredge Inc. Shimadzu Corporation NICHIREI BIOSCIENCES INC. SHIMIZU CORPORATION NIKON CORPORATION Shin Nippon Biomedical Laboratories, Ltd. (SNBL) Nippi, Incorporated Shiseido Company, Limited Nippon Express Co., Ltd. Sompo Japan Nipponkoa Insurance Inc. NIPRO CORPORATION SRD Co., Ltd. Nissan Chemical Corporation SRL, Inc. NISSIN CORPORATION Sumitomo Bakelite Co., Ltd. NISSUI PHARMACEUTICAL CO., LTD. SUMITOMO CHEMICAL Co., Ltd. NITTA Corporation Sumitomo Dainippon Pharma Co., Ltd. NOK Co. SUZUKEN CO., LTD. North American Science Associates Japan G.K. SYSMEX CORPORATION Novartis Pharma K.K. TAIYO NIPPON SANSO Corporation NSK Ltd. TAKARA BIO INC. Optima Inc. Takeda Pharmaceutical Company Limited Osaka Sanitary Co., Ltd. Takenaka Corporation Otsuka Pharmaceutical Co., Ltd. Teijin Limited Otsuka Pharmaceutical Factory, Inc. TEIJIN PHARMA LIMITED Panasonic Environmental Systems & Engineering Co., Ltd. Tella Pharma Inc. PeptiGrowth Inc. TERUMO CORPORATION PERSOL TEMPSTAFF CO., LTD. TOPPAN PRINTING CO., LTD. Pfizer Japan Inc. TOSOH CORPORATION Pharma Solutions Co., Ltd. Toyo Seikan Group Holdings, Ltd. PharmaBio Corporation Trust Express Co., Ltd. PHC Corporation UniBio Corporation RAYMEI INC. Vision Care Inc. ReproCELL Inc. VITAL KSK HOLDINGS, INC. RION CO., LTD. Wanbishi Archives Co., Ltd. Roche Diagnostics K.K. Yokogawa Electric Corporation ROHTO Pharmaceutical Co., Ltd. ZENOGEN PHARMA CO., LTD. SanBio Company Limited ZIMMER BIOMET SANKEN SETSUBI KOGYO CO., LTD. Special Members Special Members Central Institute for Experimental Animals Japan Blood Products Organization Foundation for Biomedical Research and Innovation at Kobe Japan Food Research Laboratories Supporting Members Supporting Members AIR LIQUIDE Kogyo Gas Ltd. Kondoh Industries, Ltd. ANTI-AGEING Co., Ltd. KURARAY CO., LTD. B.BRAUN AESCULAP JAPAN CO., LTD. Mitsui Chemicals, Inc. COREFRONT Corporation MUTOH CO., LTD. Corning International K.K. NIHON KOHDEN CORPORATION COSMO BIO CO., LTD. Nikon CeLL innovation Co., Ltd. Cytori Therapeutics K.K. NIPPON SHOKUBAI Co., LTD. Daewoong Pharmaceutical Co., Ltd. Nobelpharma Co., Ltd. EELS (Edogawa Evolutionary Laboratory of Science) PAREXEL International Inc. Eil Inc. PPG inc. ERNST & YOUNG SHINNIHON LLC RICOH COMPANY, LTD. Evonik Japan Co., Ltd. SCREEN Holdings Co., Ltd. FUJISOFT Tissue Engineering Co., Ltd. SEKISUI SEIKEI, LTD. Hitachi Plant Services Co., Ltd. SHIN NIPPON AIR TECHNOLOGIES CO., LTD. Human Life CORD Japan Inc. SunFlare Co., Ltd. intellim Corporation Takasago Thermal Engineering Co., Ltd. JTB Communication Design, Inc. TOMITA PHARMACEUTICAL CO., LTD. KAN Research Institute, Inc. Toshiba Corporation Individual Members Individual Members Fuyuhiko Mori Mime Egami Fumiaki Hirata Naoki Watanabe Kenji Maekawa Rika Tanaka Masato Deguchi Zen-ichi Mohri Honorary Member Toichi Takenaka Yuzo Toda 2.
Load more

Recommended publications
  • Alma Eikoh Japan Large Cap Equity Fund a Sub-Fund of Alma Capital Investment Funds SICAV
    FOR PROFESSIONAL INVESTORS ONLY Alma Eikoh Japan Large Cap Equity Fund A sub-fund of Alma Capital Investment Funds SICAV As of 31 January 2020 Eikoh Fund description • Investment objective: seek long-term capital growth by investing generally in Japanese large cap stocks (with market capitalisation in excess of US$ 1bn) • Investment process: analyse long term company fundamentals through extensive in-house bottom up research with a strong risk management ethos • Portfolio of around 25-30 companies which are well managed, profitable and with good prospects. Portfolio managers believe that Cash Flow Return on Investment and value creation are key Investment manager: ACIM (Alma Capital Investment Management) • Alma Capital Investment Management is a Luxembourg based asset management company and holds a branch office in London • ACIM manages assets of $4bn and is regulated by the Luxembourg regulator the CSSF • The portfolio managers, led by James Pulsford, worked together at Eikoh Research Investment Management managing the portfolio before joining ACIM in January 2020 Cumulative performance (%) 1 M 3 M 6 M YTD 1Y 3Y ITD ITD (annualized) I GBP Hedged C shares -0.29 4.47 12.94 -0.29 24.54 26.44 86.03 11.36 I GBP C shares -0.58 2.63 4.95 -0.58 23.80 24.93 - - I EUR Hedged C shares -0.43 4.29 12.94 -0.43 23.69 23.44 - - I JPY C shares -0.35 4.53 13.85 -0.35 25.10 26.48 - - I EUR C shares 1.36 5.60 14.74 1.36 - - - - I EUR D shares 1.36 5.58 14.67 1.36 - - - - I USD Hedged C shares -0.20 5.06 14.81 -0.20 27.84 33.92 94.05 12.47 Topix (TR) -2.14 1.21 8.88 -2.14 10.17 18.46 53.20 7.86 Fund launched on 12 June 2014 (I USD Hedged C and I GBP Hedged C shares) Portfolio characteristics Performance (Indexed - Base 100) Main indicators Fund Index Alma Eikoh Japan Large Cap Equity Fund Topix TR No.
    [Show full text]
  • Photomask Japan 2017 Poster Presentation As of March 3
    Photomask Japan 2017 Poster Presentation as of March 3 Session Session Program Date Session Title Presentation Title Name Affiliation Time No. No. Materials of and for Quartz 9-inch size Mask Blanks for ArF PSM (Phase Shift Noriyuki ULVAC COATING 9a 9a-1 Photomasks Mask) Harashima CORPORATION 9b-1 Mask crosstalk defect between develop to etch process Yuan Hsu Photronics DNP Mask Corp. 9b Process Stabilize OMOG photomask post-repair CD variation by 9b-2 Vincent Shen Photronics DNP Mask Corp. cleaning strategy and post-repair treatment Old and new techniques mixed up into optical photomask 9c-1 Jumpei Fukui Nikon Engineering Co., Ltd. measurement method Quickly Identifying and Resolving Particle Issues in 9c-2 Yukinobu Hayashi CyberOptics Corporation Photolithographic Scanners Metrology Tools and 9c Technologies Best Practices for Monitoring Humidity in Emersion Scanner 9c-3 Yukinobu Hayashi CyberOptics Corporation Reticle Environments to Reduce Reticle Haze Effects LMS IPRO: enabling accurate registration metrology on SiN- Hendrik 9c-4 KLA-Tencor MIE GmbH based Phase-Shift Masks Steigerwald Inspection Tools and Development of Photomask Insitu Inspection system for 9d 9d-1 Shingo Yoshikawa Dai Nippon Printing Co., Ltd. Technologies 1Xnm lithography mask and beyond Repairing Tools and How Smart is your BEOL? 9e 9e-1 Kristian Schulz Carl Zeiss SMT Technologies Productivity Improvement through Intelligent Automation Semiconductor Manufacturing 9f-1 Physical Model based Mask Registration Correction Rivan Li International Corp. 16:20- April 6
    [Show full text]
  • Mitsubishi Logistics Environmental and Social Report 2020
    Mitsubishi Logistics Environmental and Social Report Mitsubishi Logistics Environmental 2020 Mitsubishi Logistics Environmental and Social Report 2020 Mitsubishi Logistics Corporation Corporate Philosophy Engage in sincere and fair business activities to secure appropriate profits and promote steady growth, appropriately compensating our stakeholders while contributing to the realization of an affluent and sustainable society. Editorial Policy Contents The Mitsubishi Logistics Group (the “Group”) has issued this Editorial Policy, Tool Map and Contents 1 Environmental and Social Report each year since fiscal 2007 to fulfill its accountability about the effects of its business activities on society and Corporate History 2 the environment. Top Message 4 To disclose the goals, activity details and achievements of the Group’s CSR management, this Report describes precisely and in an Introduction of Businesses 6 easy-to-understand manner the promotion of CSR as well as each of Feature (Disaster Response) 8 the seven core subjects based on the “Guidance on Social Responsibility” (JIS Z 26000, ISO 26000). This Guidance is a global At a Glance 10 standard for CSR established by the Japanese Industrial Standards (JIS) and the International Organization for Standardization (ISO). Promotion of CSR Manifestation of The Three Principles of Mitsubishi’s Business 12 Boundary of the Report and Reporting Period Management Philosophy and the Code of Conduct, etc. Boundary of The Report covers Mitsubishi Logistics Corporation (the Promotion of CSR for every employee; Emphasis on communication 15 the Report: “Company”) and Group companies. Confirmation of major CSR activities 16 Reporting This Report covers our business activities for the period Period: from April 1, 2019 to March 31, 2020.
    [Show full text]
  • ANNUAL REPORT FY2014 for the Year Ended March 31, 2015 Courtesy of Mizushima LNG Co., Ltd
    ANNUAL REPORT FY2014 For the year ended March 31, 2015 Courtesy of Mizushima LNG Co., Ltd. Financial Highlights Years Ended March 31, 2015, 2014, 2013, 2012, and 2011 2015 2014 2013 2012 2011 For the Year (Millions of Yen) Revenues ¥480,979 ¥446,147 ¥398,918 ¥254,675 ¥247,082 Cost of revenue 435,327 404,685 356,402 215,783 215,563 Operating income 21,466 21,079 25,113 24,197 17,544 Income before income taxes and minority interests 22,012 22,538 26,747 23,543 11,476 Net income 11,029 13,447 16,077 14,364 7,979 At Year-End (Millions of Yen) Total assets ¥515,839 ¥475,288 ¥435,379 ¥365,795 ¥353,392 Profile Total equity 208,405 198,031 189,356 168,737 155,758 Current ratio (%) 151.0 156.3 166.3 165.5 173.8 Founded in 1948 in the post war period to reconstruct Japan, Chiyoda started its engi- Per Common Share (Yen) neering business for domestic projects mainly in petroleum refining, gas processing and Earnings per share (EPS) ¥42.58 ¥51.91 ¥62.06 ¥55.44 ¥30.79 petrochemical fields, and expanded into overseas projects in the 1960s. Since then, Chiyoda Book value per share (BPS) 796.89 758.31 727.24 648.95 599.15 has been and is growing steadily under the corporate philosophy of enhancing its business by aiming for harmony between energy and the environment and contributing to the Dividend per share 13.0 16.0 19.0 17.0 11.0 sustainable development of society.
    [Show full text]
  • United Japan Growth Fund
    United Japan Growth Fund Semi Annual Report for the half year ended 30 June 2021 United Japan Growth Fund (Constituted under a Trust Deed in the Republic of Singapore) MANAGER UOB Asset Management Ltd Registered Address: 80 Raffles Place UOB Plaza Singapore 048624 Company Registration No. : 198600120Z Tel: 1800 22 22 228 DIRECTORS OF UOB ASSET MANAGEMENT LTD Lee Wai Fai Eric Tham Kah Jin PehKianHeng Thio Boon Kiat TRUSTEE State Street Trust (SG) Limited 168 Robinson Road #33-01, Capital Tower Singapore 068912 CUSTODIAN / ADMINISTRATOR / REGISTRAR State Street Bank and Trust Company, acting through its Singapore Branch 168 Robinson Road #33-01, Capital Tower Singapore 068912 AUDITOR PricewaterhouseCoopers LLP 7 Straits View, Marina One East Tower, Level 12 Singapore 018936 SUB-MANAGER Fukoku Capital Management, Inc. 1-3-1 Uchisaiwaicho Chiyoda-Ku Saiwai Building 3rd Floor Tokyo 100-0011, Japan -1- United Japan Growth Fund (Constituted under a Trust Deed in the Republic of Singapore) A) Fund Performance Since Inception 18 August 3yr 5yr 10 yr 1995 3mth 6mth 1yr Ann Ann Ann Ann Fund Performance/ % % % Comp Comp Comp Comp Benchmark Returns Growth Growth Growth Ret Ret Ret Ret United Japan Growth Fund -2.42 -2.27 16.23 3.68 5.17 4.75 2.57 Benchmark -0.24 3.01 20.29 6.73 10.16 8.13 0.60 Source: Morningstar. Note: The performance returns of the Fund are in Singapore Dollar based on a NAV-to-NAV basis with dividends and distributions reinvested, if any. The benchmark of the Fund: Aug 95 – Dec 04: Nikkei 225 Stock Average; Jan 05 – Dec 10: Topix; Jan 11 to Present: MSCI Japan Index.
    [Show full text]
  • Sensor Zoom Min. Focusing Dimensions Est. Street Brand Model Mount(S) Format Range Distance (D X L) (In.) Weight Price
    Sensor Zoom Min. Focusing Dimensions Est. Street Brand Model Mount(s) Format Range Distance (D x L) (in.) Weight Price Canon EF-S 18-200mm ƒ/3.5-5.6 IS Canon APS-C 11.1x 17.8 inches 3.1 x 6.4 20.9 oz. $699 Canon EF 28-300mm ƒ/3.5-5.6L IS USM Canon Full-Frame 10.7x 27.6 inches 3.6 x 7.2 59.2 oz. $2,449 Nikon 1 NIKKOR VR 10-100mm ƒ/4-5.6 Nikon 1 CX (1-inch) 10x Variable 2.4 x 2.8 10.5 oz. $549 Nikon 1 NIKKOR VR 10-100mm ƒ/4.5-5.6 PD-ZOOM Nikon 1 CX (1-inch) 10x Variable 3.0 x 3.7 18.2 oz. $749 Nikon AF-S DX NIKKOR 18-200mm ƒ/3.5-5.6G ED VR II Nikon DX (APS-C ) 11.1x 19.2 inches 3.0 x 3.8 19.8 oz. $649 Nikon AF-S DX NIKKOR 18-300mm ƒ/3.5-6.3G ED VR Nikon DX (APS-C) 16.7x 19.2 inches 3.0 x 3.8 19.4 oz. $699 Nikon AF-S DX NIKKOR 18-300mm ƒ/3.5-5.6G ED VR Nikon DX (APS-C) 16.7x Variable 3.3 x 4.7 29.3 oz. $999 Nikon AF-S NIKKOR 28-300mm ƒ/3.5-5.6G ED VR Nikon FX (Full-Frame) 10.7x 19.2 inches 3.3 x 4.5 28.2 oz. $949 Olympus M.Zuiko ED 14-150mm ƒ/4.0-5.6 II Micro Four Thirds Micro Four Thirds 10.7x 19.7 inches 2.5 x 3.3 10.0 oz.
    [Show full text]
  • Factset-Top Ten-0521.Xlsm
    Pax International Sustainable Economy Fund USD 7/31/2021 Port. Ending Market Value Portfolio Weight ASML Holding NV 34,391,879.94 4.3 Roche Holding Ltd 28,162,840.25 3.5 Novo Nordisk A/S Class B 17,719,993.74 2.2 SAP SE 17,154,858.23 2.1 AstraZeneca PLC 15,759,939.73 2.0 Unilever PLC 13,234,315.16 1.7 Commonwealth Bank of Australia 13,046,820.57 1.6 L'Oreal SA 10,415,009.32 1.3 Schneider Electric SE 10,269,506.68 1.3 GlaxoSmithKline plc 9,942,271.59 1.2 Allianz SE 9,890,811.85 1.2 Hong Kong Exchanges & Clearing Ltd. 9,477,680.83 1.2 Lonza Group AG 9,369,993.95 1.2 RELX PLC 9,269,729.12 1.2 BNP Paribas SA Class A 8,824,299.39 1.1 Takeda Pharmaceutical Co. Ltd. 8,557,780.88 1.1 Air Liquide SA 8,445,618.28 1.1 KDDI Corporation 7,560,223.63 0.9 Recruit Holdings Co., Ltd. 7,424,282.72 0.9 HOYA CORPORATION 7,295,471.27 0.9 ABB Ltd. 7,293,350.84 0.9 BASF SE 7,257,816.71 0.9 Tokyo Electron Ltd. 7,049,583.59 0.9 Munich Reinsurance Company 7,019,776.96 0.9 ASSA ABLOY AB Class B 6,982,707.69 0.9 Vestas Wind Systems A/S 6,965,518.08 0.9 Merck KGaA 6,868,081.50 0.9 Iberdrola SA 6,581,084.07 0.8 Compagnie Generale des Etablissements Michelin SCA 6,555,056.14 0.8 Straumann Holding AG 6,480,282.66 0.8 Atlas Copco AB Class B 6,194,910.19 0.8 Deutsche Boerse AG 6,186,305.10 0.8 UPM-Kymmene Oyj 5,956,283.07 0.7 Deutsche Post AG 5,851,177.11 0.7 Enel SpA 5,808,234.13 0.7 AXA SA 5,790,969.55 0.7 Nintendo Co., Ltd.
    [Show full text]
  • Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 21LADY
    Mizuho BK Custody and Proxy Board Lot Size List OCT 27, 2020 Board Lot Stock Name (in Alphabetical Order) ＩＳＩＮ Code ＱＵＩＣＫ Code Size 21LADY CO.,LTD. 100 JP3560550000 3346 3-D MATRIX,LTD. 100 JP3410730000 7777 4CS HOLDINGS CO.,LTD. 100 JP3163300001 3726 A DOT CO.,LTD 100 JP3160590000 7063 A-ONE SEIMITSU INC. 100 JP3160660001 6156 A.D.WORKS GROUP CO.,LTD. 100 JP3160560003 2982 A&A MATERIAL CORPORATION 100 JP3119800005 5391 A&D COMPANY,LIMITED 100 JP3160130005 7745 A&T CORPORATION 100 JP3160680009 6722 ABALANCE CORPORATION 100 JP3969530009 3856 ABC-MART,INC. 100 JP3152740001 2670 ABHOTEL CO.,LTD. 100 JP3160610006 6565 ABIST CO.,LTD. 100 JP3122480001 6087 ACCESS CO.,LTD. 100 JP3108060009 4813 ACCESS GROUP HOLDINGS CO.,LTD. 100 JP3108190004 7042 ACCRETE INC. 100 JP3108180005 4395 ACHILLES CORPORATION 100 JP3108000005 5142 ACMOS INC. 100 JP3108100003 6888 ACOM CO.,LTD. 100 JP3108600002 8572 ACRODEA,INC. 100 JP3108120001 3823 ACTCALL INC. 100 JP3108140009 6064 ACTIVIA PROPERTIES INC. 1 JP3047490002 3279 AD-SOL NISSIN CORPORATION 100 JP3122030004 3837 ADASTRIA CO.,LTD. 100 JP3856000009 2685 ADEKA CORPORATION 100 JP3114800000 4401 ADISH CO.,LTD. 100 JP3121500007 7093 ADJUVANT COSME JAPAN CO.,LTD. 100 JP3119620007 4929 ADTEC PLASMA TECHNOLOGY CO.,LTD. 100 JP3122010006 6668 ADVAN CO.,LTD. 100 JP3121950004 7463 ADVANCE CREATE CO.,LTD. 100 JP3122100005 8798 ADVANCE RESIDENCE INVESTMENT CORPORATION 1 JP3047160001 3269 ADVANCED MEDIA,INC. 100 JP3122150000 3773 ADVANEX INC. 100 JP3213400009 5998 ADVANTAGE RISK MANAGEMENT CO.,LTD. 100 JP3122410008 8769 ADVANTEST CORPORATION 100 JP3122400009 6857 ADVENTURE,INC. 100 JP3122380003 6030 ADWAYS INC. 100 JP3121970002 2489 AEON CO.,LTD. 100 JP3388200002 8267 AEON DELIGHT CO.,LTD.
    [Show full text]
  • “Mirai Engineering” a Grand Opportunity for the Future
    “MIRAI ENGINEERING” A GRAND OPPORTUNITY FOR THE FUTURE ANNUAL REPORT FY2016 For the year ended March 31, 2017 CHIYODA CORPORATION ANNUAL REPORT FY2016 PROFILE Chiyoda Corporation is a leading integrated engineering and construction company with a signifi cant INDEX presence in the global oil and gas market, and customers in more than 60 countries. Especially in the fi eld 02 Profile 19 Topics 39 Risk Management of LNG plant engineering and construction, we are a global leader, with a track record of undertaking 03 At a Glance 21 Chiyoda’s ESG Initiatives 41 Corporate Information projects that account for around 40% of the world’s total LNG plant capacity. 05 To Our Shareholders 31 Corporate Governance 43 Stock Information Established in 1948, Chiyoda started with domestic projects in petroleum refining, petrochemicals 11 Financial Highlights 35 Directors & Officers and gas processing. Since the 1970s, Chiyoda has developed a powerful global footprint, taking 13 Business Overview 37 Corporate Governance Dialogue advantage of the many opportunities in the engineering, procurement and construction of energy- related plants, while building a first-class reputation for technological capability, safety and reliability. 2017 During its 70-year history, the Chiyoda Group has been growing steadily under the corporate Order awarded for the pilot plant for production of renewable jet and diesel philosophy of enhancing business by aiming for harmony between energy and the environment, while fuels for euglena Co., Ltd. in Japan contributing to the sustainable development of society. In addition, Chiyoda has expanded business 2003 Order awarded for Sakhalin ll LNG Project into the offshore and upstream sectors, new energy and renewable energies.
    [Show full text]
  • The Japan Disaster: Rebuilding Supply Chains
    3/25/2011 The Japan Disaster: Rebuilding Supply Chains March 24, 2011 Bruce C. Arntzen, PhD James B Rice, Jr. Senior Research Director Deputy Director, CTL [email protected] [email protected] W 617.252.6965 W 617.258.8584 MIT Center for Transportation and Logistics (CTL) Cambridge, MA 1 Agenda • What has happened? • What will happen? • What should companies do? 2 1 3/25/2011 What has happened: business impacts? • Primary impacts – earthquake and tsunami damaged facilities, personnel lost, destroyed communications systems in northern Japan • Automotive finished vehicles & parts (esp. engine air flow sensors & engines): Honda, Toyota, Nissan, Mazda • High tech: semiconductors, technology (e.g. LCD, silicon wafers, rechargeable batteries, DRAM, NAND, digital cameras): Sony, Hitatchi, Shin-Etsu, SUMCO, Toshiba, Nikon, Fujitsu • Pharmaceuticals (insulin, penicillin): Novo Nordisk, GSK, Roche • Others: Apparel (high tech fibers), Food (soy sauce): Kikoman • Some attempting to restart this week • Secondary impacts – loss of supply from primary impacts causing shutdowns • Retailers and downstream customers of those industries currently working off of already lean inventories and starting to see cessation or slowdowns in supply • Factories in Japan shuttered to conserve power • Unreliable utilities (power, water) continue to impact operations • Discovery of critical dependence • Hitachi engine air flow sensors • Renesas drive train microprocessors 3 Business Impacts: Capacity Losses Company Product Core Capacity Loss (Failure Brief Impact mode) Apple
    [Show full text]
  • NIKON REPORT 2018 Unleashing the Limitless Possibilities of Light
    NIKON REPORT 2018 Year Ended March 31, 2018 Unlock the future with the power of light Unleashing the limitless possibilities of light. Striving to brighten the human experience. Focused, with purpose, on a better future for all. THIS IS THE ESSENCE OF NIKON. Creation of New Value by Unlocking the Future with the Power of Light Throughout a century since its founding, Nikon has continued to win customer trust by contributing to the development of society with products and solutions based on its core opto-electronics and precision technologies. The technologies, the human resources, and the brand cultivated through this process have become reliable strengths supporting Nikon today. After completing the restructuring that began in November 2016, it will be crucial to further hone these strengths and fulfill our role as the “new eyes for people and industry” in order to create new value and support our growth strategies. Our vision formulated in 2017 will guide us in fostering corporate culture in which each employee is encouraged to think about what is necessary in order to accomplish growth and to tackle the challenges this introspection reveals. With this culture, everyone at Nikon will unite in our quest to consistently create corporate value. Nikon Report 2018 puts a spotlight on the value we have provided thus far and the strengths cultivated over the years. Moreover, the report seeks to communicate the basis for the growth strategies to be implemented after the completion of the restructuring and the tasks that will need to be addressed in order to effectively implement those strategies.
    [Show full text]
  • Whither the Keiretsu, Japan's Business Networks? How Were They Structured? What Did They Do? Why Are They Gone?
    IRLE IRLE WORKING PAPER #188-09 September 2009 Whither the Keiretsu, Japan's Business Networks? How Were They Structured? What Did They Do? Why Are They Gone? James R. Lincoln, Masahiro Shimotani Cite as: James R. Lincoln, Masahiro Shimotani. (2009). “Whither the Keiretsu, Japan's Business Networks? How Were They Structured? What Did They Do? Why Are They Gone?” IRLE Working Paper No. 188-09. http://irle.berkeley.edu/workingpapers/188-09.pdf irle.berkeley.edu/workingpapers Institute for Research on Labor and Employment Institute for Research on Labor and Employment Working Paper Series (University of California, Berkeley) Year Paper iirwps-- Whither the Keiretsu, Japan’s Business Networks? How Were They Structured? What Did They Do? Why Are They Gone? James R. Lincoln Masahiro Shimotani University of California, Berkeley Fukui Prefectural University This paper is posted at the eScholarship Repository, University of California. http://repositories.cdlib.org/iir/iirwps/iirwps-188-09 Copyright c 2009 by the authors. WHITHER THE KEIRETSU, JAPAN’S BUSINESS NETWORKS? How were they structured? What did they do? Why are they gone? James R. Lincoln Walter A. Haas School of Business University of California, Berkeley Berkeley, CA 94720 USA ([email protected]) Masahiro Shimotani Faculty of Economics Fukui Prefectural University Fukui City, Japan ([email protected]) 1 INTRODUCTION The title of this volume and the papers that fill it concern business “groups,” a term suggesting an identifiable collection of actors (here, firms) within a clear-cut boundary. The Japanese keiretsu have been described in similar terms, yet compared to business groups in other countries the postwar keiretsu warrant the “group” label least.
    [Show full text]